Understanding and optimizing use of contrast material for CT of the liver.

Improvements in CT technology have dramatically increased our ability to detect and diagnose liver abnormalities, particularly neoplastic disease. Because of the high prevalence of liver disease in patients referred for abdominal CT examinations, contrast administration and scanning techniques are usually optimized for detection of liver disease on abdominal CT scans. A wide variety of contrast techniques can be used to evaluate the liver, and it is important to understand both the rationale behind each technique and the impact on the quality of the examination when one deviates from these techniques. In addition, the timing of contrast administration and scan acquisition has become critical, and improper timing can cause lesions that are easily visualized to be obscured. This article reviews principles of lesion detection and the effects of various contrast techniques on lesion visualization.

[1]  K. Takayasu,et al.  Detection of hepatocellular carcinoma: comparison of CT during arterial portography with CT after intraarterial injection of iodized oil. , 1990, Radiology.

[2]  T. Shawker,et al.  Hepatic metastasis detection: comparison of three CT contrast enhancement methods. , 1987, Radiology.

[3]  P. Freeny,et al.  Hepatic perfusion abnormalities during CT angiography: detection and interpretation. , 1986, Radiology.

[4]  M. Bernardino,et al.  Computed tomographic arteriography of the liver. , 1979, Radiology.

[5]  F A Burgener,et al.  Contrast enhancement of hepatic tumors in CT: comparison between bolus and infusion techniques. , 1983, AJR. American journal of roentgenology.

[6]  R. Nelson Techniques for computed tomography of the liver. , 1991, Radiologic clinics of North America.

[7]  Y. Itai,et al.  Transient hepatic attenuation difference of lobar or segmental distribution detected by dynamic computed tomography. , 1982, Radiology.

[8]  J. Heiken,et al.  Detection of focal hepatic masses: prospective evaluation with CT, delayed CT, CT during arterial portography, and MR imaging. , 1989, Radiology.

[9]  P. Freeny,et al.  Colorectal carcinoma evaluation with CT: preoperative staging and detection of postoperative recurrence. , 1986, Radiology.

[10]  K Hanafusa,et al.  Small hepatocellular carcinomas: two-phase dynamic incremental CT in detection and evaluation. , 1993, Radiology.

[11]  K. Ohtomo,et al.  Transient hepatic attenuation differences on dynamic computed tomography. , 1987, Journal of computer assisted tomography.

[12]  G. Glazer,et al.  Hypervascular hepatic metastases: CT evaluation. , 1987, Radiology.

[13]  T. Chambers,et al.  Hepatic CT enhancement: comparison of ionic and nonionic contrast agents in the same patients. , 1994, Radiology.

[14]  O. Matsui,et al.  Benign and malignant nodules in cirrhotic livers: distinction based on blood supply. , 1991, Radiology.

[15]  S S Sagel,et al.  Dynamic contrast-enhanced CT of the liver: comparison of contrast medium injection rates and uniphasic and biphasic injection protocols. , 1993, Radiology.

[16]  Y. Yamaoka,et al.  Metastatic nodules of hepatocellular carcinoma: detection with angiography, CT, and US. , 1987, Radiology.

[17]  D. Elias,et al.  Detection of liver metastases from colorectal cancer: comparison of intraoperative US and CT during arterial portography. , 1992, Radiology.

[18]  M. Bernardino,et al.  Hepatic tumors: comparison of CT during arterial portography, delayed CT, and MR imaging for preoperative evaluation. , 1989, Radiology.

[19]  M. Makuuchi,et al.  CT of hilar cholangiocarcinoma: late contrast enhancement in six patients. , 1990, AJR. American journal of roentgenology.

[20]  G. Dodd,et al.  Hepatic parenchymal perfusion defects detected with CTAP: imaging-pathologic correlation. , 1992, Radiology.

[21]  H. Ohishi,et al.  Hepatocellular carcinoma detected by iodized oil. Use of anticancer agents. , 1985, Radiology.